We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,398 results
  1. Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea

    Purpose

    To investigate the rate of development of symptomatic central nervous system (CNS) demyelinating attacks or recurrent optic neuritis (ON)...

    Yeji Moon, Kyung-Ah Park, ... Jae Ho Jung in Neurological Sciences
    Article 19 October 2023
  2. Demyelinating plaque-associated uveitis

    Purpose

    To report the clinical and fluorescein angiographic (FA) features of demyelinating plaque-associated uveitis (DPU), a subset of uveitis in...

    Alireza Hedayatfar, Pasha Anvari, ... Soon-Phaik Chee in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 19 October 2023
  3. Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound

    Background

    To specify peripheral nerve affection in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) by correlating high-resolution...

    Katharina Kneer, Stephanie Straub, ... Alexander Grimm in Journal of Neurology
    Article Open access 23 January 2024
  4. Death following rapidly progressive demyelinating disorder in a young female—a case report

    Multiple sclerosis (MS) is a debilitating, demyelinating disease of the central nervous system, with manifestations ranging from numbness and...

    C. U. Wickramasinghe, D. M. G. Fernando, ... H. R. S. D. Sumanasekara in Forensic Science, Medicine and Pathology
    Article 28 November 2022
  5. Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report

    Background

    Nivolumab is an immune checkpoint inhibitor that targets the programmed cell death-1 protein and is effective in treating advanced cancer....

    Chulmin Park, Kyoung Tae Kim in BMC Neurology
    Article Open access 30 March 2023
  6. Familial coexistence of demyelinating diseases and familial Mediterranean fever

    Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterized by fever and serositis attacks caused by mutations in the MEdi...

    Cengiz Korkmaz, Döndü Üsküdar Cansu, Sibel Canbaz Kabay in Rheumatology International
    Article 13 March 2021
  7. Corneal nerve fiber involvement in chronic inflammatory demyelinating polyneuropathy

    Background

    Despite the primary myelin-related pathophysiology, small fiber neuropathy (SFN) and axonal degeneration are also considered to be involved...

    Ezgi Keskiner-Ozturk, Semra Akkaya-Turhan, ... Pinar Kahraman-Koytak in Neurological Sciences
    Article 01 March 2023
  8. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review

    Background and aims

    Although dysautonomia is a well-recognized complication of acute demyelinating polyradiculoneuropathy, it is rarely reported and...

    Łukasz Rzepiński, Pietro Emiliano Doneddu, ... Eduardo Nobile-Orazio in Neurological Sciences
    Article 21 April 2023
  9. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy

    Background

    To investigate Ranvier’s autoantibodies prevalence and isotypes in various peripheral neuropathy variants, compare clinical features...

    Lijie Zhang, Yuanyuan Zhang, ... Ying Fu in Journal of Neurology
    Article 21 May 2024
  10. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series

    Metachromatic leukodystrophy (MLD) is a neuro-metabolic disorder due to arylsulfatase A deficiency, causing demyelination of the central and...

    Shanice Beerepoot, Jaap Jan Boelens, ... Nicole I. Wolf in Journal of Neurology
    Article Open access 02 April 2024
  11. High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study

    Background

    We proposed to investigate high-dose pharmaceutical-grade biotin in a population of demyelinating neuropathies of different aetiologies, as...

    Alain Créange, Emilie Hutin, ... Jean-Pascal Lefaucheur in BMC Neurology
    Article Open access 30 October 2023
  12. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy

    Background

    Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of the most common autoimmune peripheral neuropathies in adults....

    Nan Hu, **gwen Niu, Mingsheng Liu in Neurological Sciences
    Article 23 June 2022
  13. How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

    Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy that typically presents with progressive or...

    Urvi Desai in Neurology and Therapy
    Article Open access 26 June 2023
  14. The association between cognition and gait disturbance in central nervous system demyelinating disorder with mild disability

    Introduction

    Gait disturbance in central nervous system (CNS) demyelinating disorders, including multiple sclerosis (MS) and neuromyelitis optica...

    Min Cheol Chang, Byung Joo Lee, ... Sunyoung Kim in BMC Neurology
    Article Open access 29 April 2023
  15. Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?

    Background

    Monogenic autoinflammatory disorders result in a diverse range of neurological symptoms in adults, often leading to diagnostic delays....

    Guilherme Diogo Silva, João Vitor Mahler, ... Fernando Freua in BMC Neurology
    Article Open access 17 April 2024
  16. Tumefactive Demyelinating Lesion Around a Developmental Venous Anomaly

    Alessandra Cicia, Vincenzo Carlomagno, ... Matteo Lucchini in Clinical Neuroradiology
    Article 13 June 2023
  17. FcRn Inhibitor Therapies in Neurologic Diseases

    In the last decade, the landscape of treating autoimmune diseases has evolved with the emergence and approval of novel targeted therapies. Several...

    Nouf Alfaidi, Salama Karmastaji, ... Vera Bril in CNS Drugs
    Article 09 May 2024
  18. Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis

    Introduction

    Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare progressive or relapsing inflammatory disease. Intravenous...

    Colin Anderson-Smits, Mary E. Ritchey, ... J. Bradley Layton in Neurology and Therapy
    Article Open access 12 May 2023
  19. Neuromyelitis Optica: Pathogenesis Overlap with Other Autoimmune Diseases

    Purpose of Review

    Neuromyelitis optica (NMO) is an auto-immune disease essentially depicted by optic neuritis and transverse myelitis. Per se, NMO was...

    Nadim Taheri, Julie Sarrand, Muhammad S. Soyfoo in Current Allergy and Asthma Reports
    Article 27 October 2023
  20. Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis

    Matteo Azzimonti, Monica Margoni, ... Massimo Filippi in Journal of Neurology
    Article 28 December 2023
Did you find what you were looking for? Share feedback.